SPL

2.08%

9.8¢ starpharma holdings limited

Phase 3 POR Trial, page-3

First 3 Last

Share
Profile

Follow
mukesh2001

752 Posts.

23/03/17

22:40

Post #: 23587917
Share

Originally posted by biotechcatalyst ↑

gentlemen, there seems to a LOT of confusion around this trial. let me try to clear something up, i apologise in advance if i appear rude or condescending.

1) SPL is under no obligation to announce 'the trial is now complete'. They did not announce trial completion for last Phase 3 AND MOST companies do not announce this! SPL can announce it if they want but it adds nothing.

2) They have announced full recruitment. Thats all you need! THE TOPLINE DATA which will be announced in Q2 only needs to be the PRIMARY ENDPOINT. The rest of the data, including the follow up and other secondary endpoints can be announced later and sometimes the full data isnt released until the publication of the trial in a journal which can be up to a year! THIS IS NORMAL. calm down

3) Joel you had some question bout them moving the trial and adding 2 years or something? Mate seriously? The trial is FULLY RECRUITED, it cant be moved, no more patients are needed.

4) STOP WORRYING ABOUT TRIAL COMPLETION. All that matters is when we get top-line data. SPL have said we will get topline data early to mid Q2. Theres no reason why they cant follow through with that. There are no more variables that can add months or years to this trials, its locked down!

FINALLY, remember that this trial IS NOT being conducted by SPL. Its been conducted by Quintiles FOR SPL. Quintiles is the CRO. They are good at what they do. They will generate the topline and give to SPL to announced within the time frame. Stop doing this maths trying work something out that doesnt need to worked out using logic that i dont understand.

So in conclusion. Who gives a flying fruit when the trial is 'completed'. We are getting topline in early to mid Q2. THE END.

Expand

Wasn't the milestone going to be in Jan feb ??? Will you quit if nothing comes by end q2 ??? Dare.

SPL Price at posting: 66.0¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

HLX

Helix investor makes partial takeover bid, proposing board changes

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

First 3 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.8¢		Change 0.002(2.08%)		Mkt cap ! $40.90M

Open	High	Low	Value	Volume
9.7¢	9.9¢	9.7¢	$65.08K	662.7K

Buyers (Bids)

No.	Vol.	Price($)
1	36445	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
9.9¢	64440	3

View Market Depth

No.	Vol.	Price($)
1	36445	0.098
1	128722	0.096
1	59000	0.095
1	100000	0.093
1	49413	0.091

Price($)	Vol.	No.
0.099	64440	3
0.100	101606	3
0.105	114641	4
0.110	51546	2
0.115	109827	3

Last trade - 16.10pm 30/08/2024 (20 minute delay)

SPL (ASX) Chart

Phase 3 POR Trial, page-3

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Helix investor makes partial takeover bid, proposing board changes

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Lendlease sells off US east coast construction operations in latest global divestment push

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Phase 3 POR Trial, page-3

Top Stories

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Helix investor makes partial takeover bid, proposing board changes

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Lendlease sells off US east coast construction operations in latest global divestment push

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News